Hiroshi Iwai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Iwai has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Toshio Yamashita
Center for Cancer Therapy, Kansai Medical University, Osaka 570-8507, Japan
22 shared publicationsKoichi Tomoda
Kansai Medical University Hospital, Department of Otolaryngology Head & Neck Surgery
10 shared publications- Masayuki Minamino
Department of Otorhinolaryngology, Kansai Medical University, Osaka, Japan
6 shared publications - Hiroyuki Tsuji
Departments of Head & Neck Surgery, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan
5 shared publications Jun Kita
5 shared publicationsHisaya Yukawa
Department of Otolaryngology, Kansai Medical University, Osaka 570-8507, Japan
4 shared publications
Latest Publications
- Open Access
- 11 February 2019
- Published by MDPI AG in Medical Sciences
- Vol. 7 (2) , 27
Regulation of Interaction Between the Upper and Lower Airways in United Airway Disease
The concept of united airway disease comprises allergic rhinitis (AR) with asthma, and eosinophilic chronic rhinosinusitis (ECRS) with asthma. It embodies a comprehensive approach to the treatment of upper and lower airway inflammation. The treatment of upper airway inflammation reduces asthma symptoms and decreases the dose of inhaled corticosteroids (ICS) necessary to treat asthma. However, little is known about the mechanisms of interaction between upper and lower airway inflammation. Here we review these mechanisms, focusing on neural modulation and introduce a novel therapeutic approach to united airway disease using a fine-particle ICS. Our understanding of the relationship between the upper and lower airways and its contribution to T helper 2 (Th2)-skewed disease, such as AR and/or ECRS with asthma, has led us to this novel therapeutic strategy for a comprehensive approach to the treatment of upper airway inflammation with asthma.
- 11 February 2019
- Published by MDPI AG in Medical Sciences
- Vol. 7 (2) , 27
Open AccessRegulation of Interaction Between the Upper and Lower Airways in United Airway Disease
The concept of united airway disease comprises allergic rhinitis (AR) with asthma, and eosinophilic chronic rhinosinusitis (ECRS) with asthma. It embodies a comprehensive approach to the treatment of upper and lower airway inflammation. The treatment of upper airway inflammation reduces asthma symptoms and decreases the dose of inhaled corticosteroids (ICS) necessary to treat asthma. However, little is known about the mechanisms of interaction between upper and lower airway inflammation. Here we review these mechanisms, focusing on neural modulation and introduce a novel therapeutic approach to united airway disease using a fine-particle ICS. Our understanding of the relationship between the upper and lower airways and its contribution to T helper 2 (Th2)-skewed disease, such as AR and/or ECRS with asthma, has led us to this novel therapeutic strategy for a comprehensive approach to the treatment of upper airway inflammation with asthma.
- 10 June 2018
- Published by Japan Broncho-Esophagological Society in Nihon Kikan Shokudoka Gakkai Kaiho
- Vol. 69 (3) , 204-209
A Refractory Case of Prevertebral Space Abscess in a Patient with Leukemoid Reaction after Treatment with a Tracheoesopharyngeal Shunt
われわれは,類白血病反応を呈した稀な椎前間隙膿瘍の1症例を経験したので報告する。症例は78歳の男性で,呼吸苦と気管食道廔の部分からの出血と排膿であった。CTでは椎前間隙の部分にair像を認め,採血データは白血球数が51,800/μl,芽球0.5%,骨髄球2.5%,後骨髄球2.5%を含んでいて,CRP 9.736 mg/dlであった。外科的切除術と多剤の抗生剤(SBT/ABPC, Metronidazole, MCFG)にて加療した。術後10日に,38.6度の高熱と採血データの悪化(白血球数が181,000/μl,好中球が125,000/μl)を認めた。抗生剤をTEIC, DRPM, FOM, PZFXに変更して治療した。抗生剤の治療中に,血液内科に相談し,BCR-ABLの変異を精査したが,認めなかった。さらに血液培養で緑膿菌が検出され,IL-6も上昇していたため,慢性白血病ではなく,類白血病反応と診断した。約1カ月後,類白血病反応の白血球数や他の採血データも正常範囲内に改善していた。
- 10 June 2018
- Published by Japan Broncho-Esophagological Society in Nihon Kikan Shokudoka Gakkai Kaiho
- Vol. 69 (3) , 204-209
A Refractory Case of Prevertebral Space Abscess in a Patient with Leukemoid Reaction after Treatment with a Tracheoesopharyngeal Shunt
われわれは,類白血病反応を呈した稀な椎前間隙膿瘍の1症例を経験したので報告する。症例は78歳の男性で,呼吸苦と気管食道廔の部分からの出血と排膿であった。CTでは椎前間隙の部分にair像を認め,採血データは白血球数が51,800/μl,芽球0.5%,骨髄球2.5%,後骨髄球2.5%を含んでいて,CRP 9.736 mg/dlであった。外科的切除術と多剤の抗生剤(SBT/ABPC, Metronidazole, MCFG)にて加療した。術後10日に,38.6度の高熱と採血データの悪化(白血球数が181,000/μl,好中球が125,000/μl)を認めた。抗生剤をTEIC, DRPM, FOM, PZFXに変更して治療した。抗生剤の治療中に,血液内科に相談し,BCR-ABLの変異を精査したが,認めなかった。さらに血液培養で緑膿菌が検出され,IL-6も上昇していたため,慢性白血病ではなく,類白血病反応と診断した。約1カ月後,類白血病反応の白血球数や他の採血データも正常範囲内に改善していた。
- 1 December 2017
- Published by The Japan Laryngological Association in Koutou (The Larynx Japan)
- Vol. 29 (2) , 90-93
Clinical Study of 10 Cases of the Vagus Nerve Paralysis
- 1 December 2017
- Published by The Japan Laryngological Association in Koutou (The Larynx Japan)
- Vol. 29 (2) , 90-93
Clinical Study of 10 Cases of the Vagus Nerve Paralysis
- 1 January 2016
- Published by Japan Society for Head and Neck Surgery in JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
- Vol. 26 (1) , 13-17
A clinical analysis of cases with deep neck abscesses requiring tracheotomy
- 1 January 2016
- Published by Japan Society for Head and Neck Surgery in JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
- Vol. 26 (1) , 13-17
A clinical analysis of cases with deep neck abscesses requiring tracheotomy
- Open Access
- 15 December 2015
- Published by Springer Nature in Immunity & Ageing
- Vol. 12 (1) , 1-10
Fetal thymus graft enables recovery from age-related hearing loss and expansion of CD4-Positive T cells expressing IL-1 receptor type 2 and regulatory T Cells
Accumulating evidence has indicated the relationship between the systemic immune system and the central nervous system including the inner ear. We have shown that age-related developments of T-cell dysfunction, hearing loss, and degeneration of cochlear spiral ganglion (SG) neurons observed in 6-month-old mice were recovered in 12 months old mice which previously given fetal thymus transplants twice. We have also demonstrated that CD4+ T cells expressing interleukin 1 receptor type 2 (IL-1R2) and naturally occurring regulatory T cells (nTregs), which expanded in aged 12-month-old mice, were reduced in the thymus-grafted mice of the same age. It is conceivable that the rejuvenation of systemic immune function by fetal thymus grafts contributes not only to the activation of cellular immunity but also to the decrease of IL-1R2+ CD4+ T cells or nTregs, which cells accelerate both age-related hearing loss (AHL) and neurodegeneration of the cochlear neurons. Further studies on the interactions among IL-1R2 expression on CD4+ T cells, Tregs, and neuronal cells and also on the relationships between fetal thymus grafting and the rejuvenation of systemic immunity should be designed in order to advance towards therapeutic effects on neurosenescence, including AHL.
- 15 December 2015
- Published by Springer Nature in Immunity & Ageing
- Vol. 12 (1) , 1-10
Open AccessFetal thymus graft enables recovery from age-related hearing loss and expansion of CD4-Positive T cells expressing IL-1 receptor type 2 and regulatory T Cells
Accumulating evidence has indicated the relationship between the systemic immune system and the central nervous system including the inner ear. We have shown that age-related developments of T-cell dysfunction, hearing loss, and degeneration of cochlear spiral ganglion (SG) neurons observed in 6-month-old mice were recovered in 12 months old mice which previously given fetal thymus transplants twice. We have also demonstrated that CD4+ T cells expressing interleukin 1 receptor type 2 (IL-1R2) and naturally occurring regulatory T cells (nTregs), which expanded in aged 12-month-old mice, were reduced in the thymus-grafted mice of the same age. It is conceivable that the rejuvenation of systemic immune function by fetal thymus grafts contributes not only to the activation of cellular immunity but also to the decrease of IL-1R2+ CD4+ T cells or nTregs, which cells accelerate both age-related hearing loss (AHL) and neurodegeneration of the cochlear neurons. Further studies on the interactions among IL-1R2 expression on CD4+ T cells, Tregs, and neuronal cells and also on the relationships between fetal thymus grafting and the rejuvenation of systemic immunity should be designed in order to advance towards therapeutic effects on neurosenescence, including AHL.
- Open Access
- 11 August 2012
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 47 (9) , 1061-1062
Erratum to: Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells
- 11 August 2012
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 47 (9) , 1061-1062
Open AccessErratum to: Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells
- 16 September 2011
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 46 (12) , 1368-1381
Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells
Dendritic cells (DCs) are widely distributed throughout the lymphoid and nonlymphoid tissues, and are important initiators of acquired immunity. They also serve as regulators by inducing self-tolerance. However, it has not been thoroughly clarified whether DCs are somehow involved in the regulation or treatment of inflammatory bowel diseases. We established an ileitis model by transmurally injecting 2,4,6-trinitrobenzene sulfonic acid (TNBS) into the lumen of the ileocolonic junction. The kinetic movement of DCs at the inflammatory sites was analyzed histologically and by flow cytometry, and DCs obtained from the small intestine were analyzed in order to determine the expression of paired immunoglobulin-like receptor-A/B (PIR-A/B) by flow cytometry and quantitative RT-PCR. Furthermore, the regulatory role of DCs was directly determined by a transfer experiment using TNBS-induced colitis model mice. We observed three DC subsets (PIR-A/Bhigh, PIR-A/Bmed, and PIR-A/B− DCs) in the conventional DCs (cDCs) from day 3, and the number of PIR-A/Bmed cDCs increased from the time the inflammatory responses ceased (day 7). PIR-A/Bmed cDCs actually migrated to the inflamed colon, and ameliorated the colitis induced by TNBS when transferred to colitis-induced recipients. The colitis was greatly exacerbated when mice had been treated with the indoleamine-pyrrole 2,3-dioxygenase (IDO) inhibitor 1-methyltryptophan (1-mT) at the time PIR-A/Bmed cDCs were transferred, indicating that the therapeutic ability of PIR-A/Bmed cDCs is partially dependent on IDO. The PIR-A/Bmed cDCs, which increase in number during the final stages of inflammation, can be used to treat colitis via an IDO-dependent mechanism.
- 16 September 2011
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 46 (12) , 1368-1381
Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells
Dendritic cells (DCs) are widely distributed throughout the lymphoid and nonlymphoid tissues, and are important initiators of acquired immunity. They also serve as regulators by inducing self-tolerance. However, it has not been thoroughly clarified whether DCs are somehow involved in the regulation or treatment of inflammatory bowel diseases. We established an ileitis model by transmurally injecting 2,4,6-trinitrobenzene sulfonic acid (TNBS) into the lumen of the ileocolonic junction. The kinetic movement of DCs at the inflammatory sites was analyzed histologically and by flow cytometry, and DCs obtained from the small intestine were analyzed in order to determine the expression of paired immunoglobulin-like receptor-A/B (PIR-A/B) by flow cytometry and quantitative RT-PCR. Furthermore, the regulatory role of DCs was directly determined by a transfer experiment using TNBS-induced colitis model mice. We observed three DC subsets (PIR-A/Bhigh, PIR-A/Bmed, and PIR-A/B− DCs) in the conventional DCs (cDCs) from day 3, and the number of PIR-A/Bmed cDCs increased from the time the inflammatory responses ceased (day 7). PIR-A/Bmed cDCs actually migrated to the inflamed colon, and ameliorated the colitis induced by TNBS when transferred to colitis-induced recipients. The colitis was greatly exacerbated when mice had been treated with the indoleamine-pyrrole 2,3-dioxygenase (IDO) inhibitor 1-methyltryptophan (1-mT) at the time PIR-A/Bmed cDCs were transferred, indicating that the therapeutic ability of PIR-A/Bmed cDCs is partially dependent on IDO. The PIR-A/Bmed cDCs, which increase in number during the final stages of inflammation, can be used to treat colitis via an IDO-dependent mechanism.
- 21 July 2009
- Published by Wiley in The Laryngoscope
- Vol. 119 (8) , 1491-1494
Parotid mucosa‐associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication
A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the beginning of the lymphoma. Although H. pylori was not detected in the recurrent parotid lymphoma, antibiotic therapy contributed not only to successful eradication of gastric H. pylori but also to disappearance of the recurrent lymphoma. Further studies on the mechanisms of occurrence of extragastric MALT lymphomas are needed to establish the treatment of extragastric MALT lymphomas. Laryngoscope, 2009
- 21 July 2009
- Published by Wiley in The Laryngoscope
- Vol. 119 (8) , 1491-1494
Parotid mucosa‐associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication
A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the beginning of the lymphoma. Although H. pylori was not detected in the recurrent parotid lymphoma, antibiotic therapy contributed not only to successful eradication of gastric H. pylori but also to disappearance of the recurrent lymphoma. Further studies on the mechanisms of occurrence of extragastric MALT lymphomas are needed to establish the treatment of extragastric MALT lymphomas. Laryngoscope, 2009
- 1 June 2008
- Published by Elsevier in Auris Nasus Larynx
- Vol. 35 (2) , 235-241
Preoperative concurrent chemoradiotherapy versus pre- and postoperative radiotherapy for advanced hypopharyngeal carcinoma: A single-center study
- 1 June 2008
- Published by Elsevier in Auris Nasus Larynx
- Vol. 35 (2) , 235-241
Preoperative concurrent chemoradiotherapy versus pre- and postoperative radiotherapy for advanced hypopharyngeal carcinoma: A single-center study